Skip to main navigation Skip to search Skip to main content

Differences in metabolomic profiles between Black and White women in the U.S. Analyses from two prospective cohorts

  • Emma E. McGee
  • , Oana A. Zeleznik
  • , Raji Balasubramanian
  • , Jie Hu
  • , Bernard A. Rosner
  • , Jean Wactawski-Wende
  • , Clary B. Clish
  • , Julian Avila-Pacheco
  • , Walter C. Willett
  • , Kathryn M. Rexrode
  • , Rulla M. Tamimi
  • , A. Heather Eliassen
  • Brigham and Women’s Hospital
  • Harvard University
  • The Broad Institute of MIT and Harvard
  • Cornell University

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

There is growing interest in incorporating metabolomics into public health practice. However, Black women are under-represented in many metabolomics studies. If metabolomic profiles differ between Black and White women, this under-representation may exacerbate existing Black-White health disparities. We therefore aimed to estimate metabolomic differences between Black and White women in the U.S. We leveraged data from two prospective cohorts: the Nurses’ Health Study (NHS; n = 2077) and Women’s Health Initiative (WHI; n = 2128). The WHI served as the replication cohort. Plasma metabolites (n = 334) were measured via liquid chromatography-tandem mass spectrometry. Observed metabolomic differences were estimated using linear regression and metabolite set enrichment analyses. Residual metabolomic differences in a hypothetical population in which the distributions of 14 risk factors were equalized across racial groups were estimated using inverse odds ratio weighting. In the NHS, Black-White differences were observed for most metabolites (75 metabolites with observed differences ≥|0.50| standard deviations). Black women had lower average levels than White women for most metabolites (e.g., for N6, N6-dimethlylysine, mean Black-White difference = − 0.98 standard deviations; 95% CI: − 1.11, − 0.84). In metabolite set enrichment analyses, Black women had lower levels of triglycerides, phosphatidylcholines, lysophosphatidylethanolamines, phosphatidylethanolamines, and organoheterocyclic compounds, but higher levels of phosphatidylethanolamine plasmalogens, phosphatidylcholine plasmalogens, cholesteryl esters, and carnitines. In a hypothetical population in which distributions of 14 risk factors were equalized, Black-White metabolomic differences persisted. Most results replicated in the WHI (88% of 272 metabolites available for replication). Substantial differences in metabolomic profiles exist between Black and White women. Future studies should prioritize racial representation.

Original languageEnglish
Pages (from-to)653-665
Number of pages13
JournalEuropean Journal of Epidemiology
Volume39
Issue number6
DOIs
StatePublished - Jun 2024

Keywords

  • Counterfactual analysis
  • Health disparities
  • Metabolomics
  • Race
  • Racial differences

Fingerprint

Dive into the research topics of 'Differences in metabolomic profiles between Black and White women in the U.S. Analyses from two prospective cohorts'. Together they form a unique fingerprint.

Cite this